IBDEI1D3 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24434,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,24434,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,24434,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,24435,0)
 ;;=250.01^^145^1526^4
 ;;^UTILITY(U,$J,358.3,24435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24435,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,24435,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,24435,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,24436,0)
 ;;=272.0^^145^1526^22
 ;;^UTILITY(U,$J,358.3,24436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24436,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,24436,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,24436,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,24437,0)
 ;;=272.1^^145^1526^28
 ;;^UTILITY(U,$J,358.3,24437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24437,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,24437,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,24437,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,24438,0)
 ;;=272.2^^145^1526^24
 ;;^UTILITY(U,$J,358.3,24438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24438,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,24438,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,24438,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,24439,0)
 ;;=275.42^^145^1526^21
 ;;^UTILITY(U,$J,358.3,24439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24439,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,24439,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,24439,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,24440,0)
 ;;=275.41^^145^1526^29
 ;;^UTILITY(U,$J,358.3,24440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24440,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,24440,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,24440,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,24441,0)
 ;;=276.7^^145^1526^23
 ;;^UTILITY(U,$J,358.3,24441,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24441,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,24441,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,24441,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,24442,0)
 ;;=275.2^^145^1526^19
 ;;^UTILITY(U,$J,358.3,24442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24442,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,24442,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,24442,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,24443,0)
 ;;=276.0^^145^1526^25
 ;;^UTILITY(U,$J,358.3,24443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24443,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,24443,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,24443,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,24444,0)
 ;;=276.1^^145^1526^32
 ;;^UTILITY(U,$J,358.3,24444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24444,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,24444,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,24444,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,24445,0)
 ;;=275.3^^145^1526^20
 ;;^UTILITY(U,$J,358.3,24445,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24445,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,24445,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,24445,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,24446,0)
 ;;=240.0^^145^1526^14
 ;;^UTILITY(U,$J,358.3,24446,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24446,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,24446,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,24446,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,24447,0)
 ;;=241.1^^145^1526^13
 ;;^UTILITY(U,$J,358.3,24447,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24447,1,4,0)
 ;;=4^241.1
